
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
[ Fri, Mar 17th 2023 ]: WOPRAI
Ed Arce Reiterated (ACXP) at Strong Buy and Held Target at $14 on, Mar 17th, 2023


🞛 This publication is a summary or evaluation of another publication
Ed Arce of HC Wainwright & Co., Reiterated "Acurx Pharmaceuticals, Inc." (ACXP) at Strong Buy and Held Target at $14 on, Mar 17th, 2023.
-
Ed, nor any peers, have made any analyst calls on ACXP in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30